Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14201 - 14225 of 14425 in total
Posizolid (AZD2563) is an oxazolidinone antibiotic. In July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial results (though no results were reported).
Investigational
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Investigational
Experimental
Displaying drugs 14201 - 14225 of 14425 in total